Market Value and Patent Citations: A First Look
By Bronwyn H Hall, Adam B. Jaffe, M. Trajtenberg. 2000
931 citations recorded by the source corpus.
Subfields: Economics and Econometrics, Management of Technology and Innovation
View Paper: https://www.semanticscholar.org/paper/9df8e6a394880011e75e9ac0a744315d13d3b3e3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
- Alex Coad
- Rekha Rao
- Adam B. Jaffe
- Mark Schankerman
- Bronwyn H Hall
- Richard G. Newell
- R. Stavins
- M. Reitzig
In Management of Technology and Innovation
- Rekha Rao
- Stefano Breschi
- Lee Fleming
- Mark Schankerman
- M. Reitzig
- Jason Owen-Smith
- Walter W. Powell
- Carolin Haeussler
Citations in the corpus
- R&D Networks: Theory, Empirics, and Policy Implications (2019, methodology): “Furthermore, we use information on R&D expenditures to compute R&D capital stocks using a perpetual inventory method with a 15% depreciation rate [following Bloom et al., 2013; Hall et al., 2000].”
- Special Issue on Design and Development: Recombinant Uncertainty in Technological Search (2001, background): “While there appears to be strong correlation between the rates of early and later citations to a patent, researchers are actively pursuing the topic (Hall et al. 2000).”
- Handbook of Quantitative Science and Technology Research: The Use of Publication and Patent Statistics in Studies of S&T Systems (2004, neutral): “Several studies have measured the value of a firm by its citation–weighted patent stock (Hall et al., 2000; Shane and Klock, 1997; Austin, 1994).”
- Innovation and the Market Value of UK Firms, 1989-1995 (2002, neutral): “For example, Hall et al. (2000), use patent citations as a proxy for the importance of the knowledge contained in a patent and find that the average number of citations per patent appears to add significantly to the explanation of market value.”
- Does governmental venture capital spur invention and innovation? Evidence from young European biotech companies (2015, methodology): “Our paper sheds light on the effectiveness of governmentsponsored equity investments in supporting invention and 7 In the main regressions we use a depreciation rate of 15%, as in Bertoni et al. (2010b), Griliches (1998), and Hall et al. (2000).”